Citation Impact
Citing Papers
Prolyl peptidases: a serine protease subfamily with high potential for drug discovery
2003
Computerized Automated Reminder Diabetes System (CARDS): E-Mail and SMS Cell Phone Text Messaging Reminders to Support Diabetes Management
2009 Standout
Discovery and engineering of enhanced SUMO protease enzymes
2018 StandoutNobel
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Dipeptidyl peptidase IV inhibitors: A promising new therapeutic approach for the management of type 2 diabetes
2005
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
2010
Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005
2006
Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors
2005
Co‐stimulation of human breast cancer cells with transforming growth factor‐β and tenascin‐C enhances matrix metalloproteinase‐9 expression and cancer cell invasion
2004
The biology of incretin hormones
2006 Standout
Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys
2008
The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1
2005
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold – A Potential Therapeutic Intervention for Skin Diseases
2016 StandoutNobel
Biology of Incretins: GLP-1 and GIP
2007 Standout
Aminomethylpyrimidines as novel DPP-IV inhibitors: A 105-fold activity increase by optimization of aromatic substituents
2004
Recombinant protein expression in Escherichia coli: advances and challenges
2014 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Glucagon-like peptide 1(GLP-1) in biology and pathology
2005
How were new medicines discovered?
2011 Standout
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
2013 StandoutNature
Insulin and insulin resistance:
2004 Standout
The Physiology of Glucagon-like Peptide 1
2007 Standout
Recent advances in molecular imprinting technology: current status, challenges and highlighted applications
2011 Standout
SUMO fusion technology for difficult-to-express proteins
2005
Structure and function studies of glucagon‐like peptide‐1 (GLP‐1): the designing of a novel pharmacological agent for the treatment of diabetes
2005
Synthesis and anti-HIV-1 activities of new pyrimido[5,4-b]indoles
1999
Molecularly imprinted polymers as antibody and receptor mimics for assays, sensors and drug discovery
2004
METABOLIC ACTIVATION OF FLUOROPYRROLIDINE DIPEPTIDYL PEPTIDASE-IV INHIBITORS BY RAT LIVER MICROSOMES
2004
Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig
2005
The emerging roles of human tissue kallikreins in cancer
2004
A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa
2003
The Role of Dipeptidyl Peptidase IV in the Cleavage of Glucagon Family Peptides
2003
Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV
2003
Current literature in diabetes
2001
Can Gut Hormones Control Appetite and Prevent Obesity?
2008
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic β-Cell Mass and Function in a Rodent Model of Type 2 Diabetes
2006
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
1994 StandoutNobel
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties
2003
The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion
2002
Therapeutic Strategies Based on Glucagon-Like Peptide 1
2004
Sunflower trypsin inhibitor (SFTI-1) analogues of synthetic and biological origin via N→S acyl transfer: potential inhibitors of human Kallikrein-5 (KLK5)
2014 StandoutNobel
A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.
1993
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates β-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats
2003
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Catalytic Asymmetric Protonation of Silyl Ketene Imines
2013 StandoutNobel
Indoles and pyridazino[4,5-b]indoles as nonnucleoside analog inhibitors of HIV-1 reverse transcriptase
1995
The role of medicinal plants in the treatment of diabetes: a systematic review
2016 Standout
Biological importance of the indole nucleus in recent years: A comprehensive review
2010 Standout
A Medicinal Chemist’s Guide to Molecular Interactions
2010 Standout
Works of D. Michael Evans being referenced
A Synthetic Tissue Kallikrein Inhibitor Suppresses Cancer Cell Invasiveness
2001
Solid and solution phase syntheses of the 2-cyanopyrrolidide DPP-IV inhibitor NVP-DPP728
2002
Chronic Inhibition of Circulating Dipeptidyl Peptidase IV by FE 999011 Delays the Occurrence of Diabetes in Male Zucker Diabetic Fatty Rats
2002
Metal affinity chromatography of recombinant HIV‐1 reverse transcriptase containing a human renin cleavable metal binding domain
1991